Literature DB >> 27928594

Pulmonary hypertension in rheumatic mitral stenosis revisited.

L Pourafkari1,2, S Ghaffari1, M Ahmadi1, A Tajlil1, N Aslanabadi1, N D Nader3,4.   

Abstract

BACKGROUND: In patients with mitral stenosis (MS), pulmonary hypertension (PH) is a significant contributor to the associated morbidity. We aimed to study factors associated with the presence of significant PH (sPH) and whether incorporating body surface area (BSA) in the mitral valve area (MVA) would improve the predictive value of the latter.
METHODS: The medical records of 558 patients with severe MS undergoing percutaneous balloon mitral commissurotomy were evaluated over a period of 8 years. Factors associated with the presence of significant PH (sPH) defined as mPAP ≥ 40 mm Hg were examined.
RESULTS: A total of 558 patients (423 women) were enrolled. Overall, 153 (27%) patients had sPH. Patients with sPH were similar to the rest of the subjects in terms of demographics, body habitus, blood group, and incidence of atrial fibrillation. Among echocardiographic findings, absolute MVA, indexed MVA, and mean transmitral valve gradient were associated with the presence of sPH. Transmitral valve gradient during right heart catheterization had the highest area under the curve for an association with sPH.
CONCLUSION: Age, gender, heart rhythm, and blood group were not associated with the presence of sPH in severe MS. The predictive value of the indexed MVA for the presence of sPH was not higher than that of absolute MVA.

Entities:  

Keywords:  Body surface area; Hemodynamics; Mitral valve stenosis; Pulmonary hypertension; Rheumatic heart disease

Mesh:

Year:  2016        PMID: 27928594     DOI: 10.1007/s00059-016-4509-2

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  22 in total

Review 1.  Mitral stenosis and percutaneous mitral valvuloplasty (part 1).

Authors:  Enio E Guérios; Ronaldo Bueno; Deborah Nercolini; José Tarastchuk; Paulo Andrade; Alvaro Pacheco; Alysson Faidiga; Stefan Negrao; Antonio Barbosa
Journal:  J Invasive Cardiol       Date:  2005-07       Impact factor: 2.022

2.  Clinical implications of pulmonary hypertension in mitral stenosis.

Authors:  A Walston; R H Peter; J J Morris; Y Kong; V S Behar
Journal:  Am J Cardiol       Date:  1973-10       Impact factor: 2.778

3.  Mitral valve replacement. Review of seven years' experience.

Authors:  H Najafi; W S Dye; H Javid; J A Hunter; W E Ostermiller; O C Julian
Journal:  Am J Cardiol       Date:  1969-09       Impact factor: 2.778

Review 4.  World Health Organization Pulmonary Hypertension group 2: pulmonary hypertension due to left heart disease in the adult--a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation.

Authors:  James C Fang; Teresa DeMarco; Michael M Givertz; Barry A Borlaug; Gregory D Lewis; J Eduardo Rame; Mardi Gomberg-Maitland; Srinivas Murali; Robert P Frantz; Dana McGlothlin; Evelyn M Horn; Raymond L Benza
Journal:  J Heart Lung Transplant       Date:  2012-09       Impact factor: 10.247

5.  [Guidelines on the management of valvular heart disease (version 2012). The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)].

Authors:  Alec Vahanian; Ottavio Alfieri; Felicita Andreotti; Manuel J Antunes; Gonzalo Baron-Esquivias; Helmut Baumgartner; Michael Andrew Borger; Thierry P Carrel; Michele De Bonis; Arturo Evangelista; Volkmar Falk; Bernard Iung; Patrizio Lancellotti; Luc Pierard; Susanna Price; Hans-Joachim Schafers; Gerhard Schuler; Janina Stepinska; Karl Swedberg; Johanna Takkenberg; Ulrich Otto Von Oppell; Stephan Windecker; Jose Luis Zamorano; Marian Zembala
Journal:  G Ital Cardiol (Rome)       Date:  2013-03

6.  Echocardiographic predictors of pulmonary hypertension in patients with severe aortic stenosis.

Authors:  Nikhil Kapoor; Padmini Varadarajan; Ramdas G Pai
Journal:  Eur J Echocardiogr       Date:  2008-01

7.  Pulmonary hypertension: the role of the electrocardiogram.

Authors:  I R Henkens; R W C Scherptong; K W van Kralingen; S A M Said; H W Vliegen
Journal:  Neth Heart J       Date:  2008-08       Impact factor: 2.380

8.  Factors associated with atrial fibrillation in rheumatic mitral stenosis.

Authors:  Leili Pourafkari; Samad Ghaffari; George R Bancroft; Arezou Tajlil; Nader D Nader
Journal:  Asian Cardiovasc Thorac Ann       Date:  2014-04-02

9.  The impact of concomitant pulmonary hypertension on early and late outcomes following surgery for mitral stenosis.

Authors:  Bo Yang; Christina DeBenedictus; Tessa Watt; Sean Farley; Alona Salita; Whitney Hornsby; Xiaoting Wu; Morley Herbert; Donald S Likosky; Steven F Bolling
Journal:  J Thorac Cardiovasc Surg       Date:  2016-02-24       Impact factor: 5.209

10.  Pulmonary artery hypertension in mitral stenosis: Role of right ventricular stroke volume, atrio-ventricular compliance, and pulmonary venous compliance.

Authors:  Praveen Kumar Neema; Ramesh Chandra Rathod
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2012-04
View more
  1 in total

1.  Pulmonary Hypertension in Aortic and Mitral Valve Disease.

Authors:  Micha T Maeder; Lukas Weber; Marc Buser; Marc Gerhard; Philipp K Haager; Francesco Maisano; Hans Rickli
Journal:  Front Cardiovasc Med       Date:  2018-05-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.